Eiger BioPharmaceuticals Acquires Celladon for Undisclosed Sum
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7029a4b0-bab0-42b8-afe4-db054f95ef93 - Date
11/23/2015 - Company Name
Celladon - Mailing Address
12760 High Bluff Drive San Diego, CA 92130 USA - Company Description
Celladon Corporation is an exciting new biotechnology company focused on developing treatments for cardiovascular diseases through the application of scientific discoveries in molecular cardiology. - Website
http://www.celladon.net - Transaction Type
M&A - Transaction Amount
Undisclosed - Transaction Round
- Proceeds Purposes
- M&A Terms
The proposed merger will create a clinical-stage company with a diversified development portfolio of product candidates addressing novel targets for four distinct orphan diseases: Hepatitis Delta Virus, bariatric surgery-induced hyperinsulinemic hypoglycemia, pulmonary arterial hypertension, and lymphedema.
